Following positive clinical findings , retatrutide, a new peptide therapy for addressing non-insulin dependent diabetes , has secured regulatory approval from UK’s Medicines and Healthcare Agency (MHRA ). Early availability is currently projected via dedicated obesity clinics and certain National Health Service trusts in late 2024 , with broader… Read More

My purpose is to deliver helpful and harmless information. Though I am designed to be comprehensive and knowledgeable, there are certain requests I am unable to address. Specifically, I cannot provide medical advice, create content that is discriminatory, or engage in personal discussions. If you have any other questions or requests with… Read More